Anterior uveitis
MONDO:0006651Inflammation of the iris and anterior chamber of the eye.
Also known as: anterior uveitis, anterior uveitis (disease), iridocyclitis
22 clinical trials for this condition and its sub-types, 8 tagged with Anterior uveitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Anterior uveitis
-
Non-infectious anterior uveitis 7 trials
3 sub-types
- Fuchs heterochromic iridocyclitis 0 trials
- Phacoanaphylactic uveitis 0 trials
- Sympathetic ophthalmia 0 trials
-
Iridocyclitis 1 trial · 6 incl. sub-types
3 sub-types
- Infectious anterior uveitis 5 trials · 6 incl. sub-types Sub-types →
- Glaucomatocyclitic crisis 0 trials
- Lens-induced iridocyclitis 0 trials
-
Idiopathic anterior uveitis 0 trials
Most studied deeper sub-types
-
Can a new eye drop tame uveitis inflammation without steroids?
Disease control OngoingThis trial tests an experimental eye drop called VVN461 in people with non-infectious anterior uveitis, a condition causing inflammation inside the front of the eye. Participants receive either VVN461 or a standard steroid eye drop for four weeks. The study measures whether VVN46…
Phase 3 • Sponsor: VivaVision Biotech, Inc • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New pill could tame debilitating eye inflammation, major trial underway
Disease control OngoingThis study tests an oral medication called brepocitinib in adults with active uveitis, a condition causing inflammation inside the eye. The goal is to see if the drug can prevent the disease from worsening and help maintain vision. About 371 participants will receive either the d…
Phase 3 • Sponsor: Priovant Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Eye fluid test may personalize uveitis treatment
Knowledge-focused OngoingThis study tests whether analyzing fluid from the eye can predict which immunosuppressive drug will work best for people with non-infectious uveitis, an eye inflammation condition. About 220 participants who haven't responded well to steroids will provide eye fluid and blood samp…
Sponsor: University of Milan • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC